PRXL2A and oral cavity squamous cell carcinoma: However, in oral squamous cell carcinoma, repression of miR-125b by peroxiredoxin like 2A (PRXL2A) protected cancer cells from drug-induced oxidative stress in an NRF2-depedent manner99, indicating the mutual regulation between miR-125b and NRF2.